New Zealand markets open in 8 hours 41 minutes
  • NZX 50

    12,197.15
    +44.95 (+0.37%)
     
  • NZD/USD

    0.6307
    -0.0022 (-0.35%)
     
  • ALL ORDS

    7,745.90
    -25.90 (-0.33%)
     
  • OIL

    73.61
    +0.22 (+0.30%)
     
  • GOLD

    1,885.60
    +9.00 (+0.48%)
     

Vascular Patches Market by Material, Application, End User and Region - Global Forecast to 2027

Company Logo
Company Logo

Global Vascular Patches Market

Global Vascular Patches Market
Global Vascular Patches Market

Dublin, Dec. 06, 2022 (GLOBE NEWSWIRE) -- The "Vascular Patches Market by Material (Biologic, Synthetic), Application (Open Repair of Abdominal Aortic Aneurysm, Congenital Heart Disease, Carotid Endarterectomy), End User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The global vascular patches market is valued at an estimated USD 353 million in 2022 and is projected to reach USD 517 million by 2027, at a CAGR of 7.9% during the forecast period.

Report Attribute

Details

No. of Pages

133

Forecast Period

2022 - 2027

Estimated Market Value (USD) in 2022

$353 Million

Forecasted Market Value (USD) by 2027

$517 Million

Compound Annual Growth Rate

7.9%

Regions Covered

Global

The biologic vascular patches held the largest share of the vascular patches market, by material

Based on material, the global vascular patches market is segmented into biological and synthetic vascular patches. Biologic vascular patches held a significant share in the market. It is also the fastest-growing material segment in this market. Growth in this segment is primarily driven by the advantages offered by the biologic patches over their synthetic counterparts.

The vascular bypass surgery segment is the fastest growing segment of the vascular patches market, by application

Based on application, the vascular patches market is segmented into carotid endarterectomy (CEA), open repair of abdominal aortic aneurysm (AAA), congenital heart diseases, vascular bypass surgery, and other applications. The vascular bypass surgery is expected to witness the fastest growth during the forecast period. The high growth rate of vascular bypass surgery can be attributed to the availability of reimbursement in emerging and developed economies.

Among the end users, the hospitals segment is anticipated to register the highest growth during the forecast period

Based on end users, the vascular patches market is segmented into hospitals and ambulatory surgical centers. The hospitals segment is anticipated to witness growth at the highest rate during the forecast period. The growth can be attributed to the increasing number of hospitals offering better healthcare services and infrastructure.

The Asia Pacific market is expected to grow at the highest CAGR during the forecast period

The global vascular patches market is segmented into four regions - North America, Europe, the Asia Pacific, and the Rest of the World. The Asia Pacific region is expected to witness the highest growth in the vascular patches market during the forecast period. The high growth in this region can primarily be attributed to the large number of the target population and improved healthcare infrastructures in Southeast Asian countries.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Vascular Patches Market Overview
4.2 Asia-Pacific: Vascular Patches Market, by Material (2021)
4.3 Vascular Patches Market: Geographic Growth Opportunities
4.4 Vascular Patches Market: Geographic Mix
4.5 Vascular Patches Market: Developed vs. Emerging Economies

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence of CVD
5.2.1.2 Growing Geriatric Population and Subsequent Prevalence of Vascular Diseases
5.2.1.3 Rising Number of Cardiovascular Surgeries Worldwide
5.2.1.4 Availability of Reimbursement for Vascular Procedures
5.2.1.5 Growing Adoption of Biological Patches
5.2.2 Restraints
5.2.2.1 High Procedural Cost of Vascular Surgeries and Associated Products
5.2.2.2 Product Failures and Recalls
5.2.3 Opportunities
5.2.3.1 Emerging Economies
5.2.3.2 Growth in the Number of Hospitals & Surgical Centers
5.2.4 Challenges
5.2.4.1 Lack of Skilled Professionals
5.3 Regulatory Landscape
5.4 Porter's Five Forces Analysis
5.5 Technology Analysis
5.6 Value Chain Analysis
5.7 Supply Chain Analysis
5.8 Ecosystem Analysis
5.8.1 Ecosystem Role

6 Vascular Patches Market, by Material
6.1 Introduction
6.2 Biologic Vascular Patches
6.2.1 Wide Usage in Arterial Closure During Cardiac Surgeries to Drive Market
6.3 Synthetic Vascular Patches
6.3.1 High Risk of Infection Despite Being Cost-Efficient to Restrain Market

7 Vascular Patches Market, by Application
7.1 Introduction
7.2 Carotid Endarterectomy
7.2.1 Increasing Patch Angioplasty Procedures to Drive Market
7.3 Vascular Bypass Surgery
7.3.1 Rising Prevalence of Vascular Diseases to Drive Market
7.4 Congenital Heart Disease
7.4.1 Use of Synthetic & Biologic Vascular Patches for Corrective Surgeries to Drive Market
7.5 Open Repair of Abdominal Aortic Aneurysm
7.5.1 Rising Incidence of Aaa to Drive Demand for Vascular Patches
7.6 Other Applications

8 Vascular Patches Market, by End-user
8.1 Introduction
8.2 Hospitals
8.2.1 Rising Burden of CVD and Developing Infrastructure in Emerging Economies to Drive Market
8.3 Ambulatory Surgical Centers
8.3.1 Rising Number of Ascs to Propel Market Growth

9 Vascular Patches Market, by Region

10 Competitive Landscape
10.1 Overview
10.2 Strategies Adopted by Key Players
10.3 Revenue Share Analysis
10.4 Market Share Analysis
10.5 Company Evaluation Quadrant
10.5.1 Stars
10.5.2 Emerging Leaders
10.5.3 Pervasive Players
10.5.4 Participants
10.6 Company Footprint Analysis
10.7 Competitive Scenario
10.7.1 Deals
10.7.2 Other Developments

11 Company Profiles
11.1 Key Players
11.1.1 Baxter International, Inc.
11.1.2 Lemaitre Vascular, Inc.
11.1.3 W. L. Gore & Associates, Inc.
11.1.4 Getinge Ab
11.1.5 B. Braun
11.1.6 Edwards Lifesciences Corporation
11.1.7 Becton, Dickinson and Company
11.1.8 Aziyo Biologics, Inc.
11.1.9 Terumo Corporation
11.1.10 Artivion, Inc.
11.1.11 Labcor Laboratorios Ltda.
11.2 Other Players
11.2.1 Vup Medical
11.2.2 Aegis Lifesciences
11.2.3 Synkromax Biotech Pvt. Ltd.

12 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/rxbsi3

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900